Monica Montes
6Patents
5h-index
10Co-inventors
52Inventor score
Filing activity: Jul 16, 2009 → Oct 18, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8518410B2 | Fusion protein with HIV antigen | Emerging Cross-Sectional Technologies | 40 | Active |
| US8961991B2 | Anti-CD40 targeted fusion proteins | Emerging Cross-Sectional Technologies | 38 | Active |
| US9416186B2 | Antigen presenting cell targeted anti-viral vaccines | Emerging Cross-Sectional Technologies | 25 | Active |
| US9109011B2 | Dendritic cell-specific antibody conjugate comprising anti-CD40 monoclonal antibodies conjugated to HIV-1 Gag/Nef | Chemistry; Metallurgy | 13 | Active |
| US9862927B2 | Dendritic cell vaccines | Chemistry; Metallurgy | 7 | Active |
| US10988544B2 | Fusion proteins comprising an anti-CD40 antibody and HIV antigenic peptides | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.